ANGPTL4 and coronary artery disorder: These findings are relevant for drugs that inhibit ANGPTL47 or directly enhance LPL by disrupting the inhibitory activity of ANGPTL4.17 Second, rare loss-of-function variants in ANGPTL3 are associated with a greater level of protection from coronary disease than other genetic mechanisms for a given genetic difference in LDL-C levels.